Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options

JCO Sardi, L Scorzoni, T Bernardi… - Journal of medical …, 2013 - microbiologyresearch.org
The incidence of fungal infections has increased significantly, so contributing to morbidity
and mortality. This is caused by an increase in antimicrobial resistance and the restricted …

Mechanisms of Candida Biofilm Drug Resistance

HT Taff, KF Mitchell, JA Edward, DR Andes - Future microbiology, 2013 - Taylor & Francis
Candida commonly adheres to implanted medical devices, growing as a resilient biofilm
capable of withstanding extraordinarily high antifungal concentrations. As currently available …

Antifungal therapy with an emphasis on biofilms

CG Pierce, A Srinivasan, P Uppuluri… - Current opinion in …, 2013 - Elsevier
Highlights•Fungal infections affect an expanding population of immunosuppressed
patients.•The current arsenal of antifungal drugs is exceedingly limited.•Toxicity problems …

Enterococcus faecalis inhibits hyphal morphogenesis and virulence of Candida albicans

MR Cruz, CE Graham, BC Gagliano… - Infection and …, 2013 - Am Soc Microbiol
ABSTRACT The Gram-positive bacterium Enterococcus faecalis and the fungus Candida
albicans are both found as commensals in many of the same niches of the human body …

Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs

CG Pierce, JL Lopez-Ribot - Expert opinion on drug discovery, 2013 - Taylor & Francis
Introduction: Targeting pathogenetic mechanisms, rather than essential processes,
represents a very attractive alternative for the development of new antibiotics. This may be …

Effect of jujube honey on Candida albicans growth and biofilm formation

MJ Ansari, A Al-Ghamdi, S Usmani, NS Al-Waili… - Archives of medical …, 2013 - Elsevier
Background and Aims Candida species, especially Candida albicans, are major fungal
pathogens of humans that are capable of causing superficial mucosal infections and …

High-throughput screening of a collection of known pharmacologically active small compounds for identification of Candida albicans biofilm inhibitors

SA Siles, A Srinivasan, CG Pierce… - Antimicrobial agents …, 2013 - Am Soc Microbiol
Candida albicans is the most common etiologic agent of systemic fungal infections with
unacceptably high mortality rates. The existing arsenal of antifungal drugs is very limited and …

The inhibitory activity of linalool against the filamentous growth and biofilm formation in Candida albicans

CC Hsu, WL Lai, KC Chuang, MH Lee… - Medical …, 2013 - academic.oup.com
Candida spp. are part of the natural human microbiota, but they also represent important
opportunistic human pathogens. Biofilm-associated Candida albicans infections are …

Antifungal lock therapy

CJ Walraven, SA Lee - Antimicrobial agents and chemotherapy, 2013 - Am Soc Microbiol
The widespread use of intravascular devices, such as central venous and hemodialysis
catheters, in the past 2 decades has paralleled the increasing incidence of catheter-related …

Spaceflight Enhances Cell Aggregation and Random Budding in Candida albicans

A Crabbé, SM Nielsen-Preiss, CM Woolley, J Barrila… - PloS one, 2013 - journals.plos.org
This study presents the first global transcriptional profiling and phenotypic characterization
of the major human opportunistic fungal pathogen, Candida albicans, grown in spaceflight …